Medicxi III Overview
Medicxi III General Information
Description
Medicxi III is a venture capital fund managed by Medicxi. The fund is located in London, United Kingdom and invests in Europe. The fund targets investments in the life sciences and biotechnology sectors.
Contact Information
Fund Manager's Location
- 25 Great Pulteney Street
- London W1F 9LT
- England, United Kingdom
Medicxi III Investments (18)
Medicxi III has made a total of 18 investments. Its most recent deal was a with Altesa BioSciences for . The deal was made on 22-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Altesa BioSciences | 22-Jun-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Graegis Pharmaceuticals | 06-Dec-2022 | Drug Delivery | Clinical Trials - General | |||
| T-Cypher Bio | 27-Jul-2022 | Drug Discovery | Generating Revenue | |||
| MiroBio | 29-Jun-2022 | Biotechnology | Generating Revenue | |||
| Xenikos | 02-Sep-2021 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Sydnexis | 10-Aug-2021 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Rivus Pharmaceuticals | 20-Jul-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Kurome Therapeutics | 10-Jun-2021 | Biotechnology | Pre-Clinical Trials | |||
| Kaerus Bioscience | 23-Apr-2021 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Monopteros Therapeutics | 22-Apr-2021 | Early Stage VC (Series A) | Drug Discovery | Clinical Trials - Phase 1 |
Medicxi III Investment Strategy
Investments by Industry
Investments by Deal Type
Medicxi III Limited Partners (11)
European Investment Fund is one of Medicxi III’s 11 limited partners. Its latest Original was on 19-Jul-2019.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| European Investment Fund | Current | 19-Jul-2019 | Original | ||
| Farmers Property and Casualty Insurance Company | Current | 19-Jul-2019 | Original | ||
| GSK | Current | 19-Jul-2019 | Original | ||
| Johnson & Johnson Innovation - JJDC | Current | 19-Jul-2019 | Original | ||
| Kommunal Landspensjonskasse | Insurance Company | Current | 19-Jul-2019 | Original |
Medicxi III Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Medicxi III Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Medicxi III Benchmark (12)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Venture Fund II | |||||
| Mouro Capital I | |||||
| Rocket Internet Capital Partners II | |||||
| Top Tier European Venture Capital Fund II | |||||
| Crown Growth Opportunities Europe III | 31-Mar-2025 | ||||
| SL Capital Fund I | |||||
| SV7 Impact Medicine Fund | 31-Dec-2024 | ||||
| 83North V | |||||
| Partners Capital Condor Fund XI | |||||
| OGCI Climate Investments Fund |
Medicxi III FAQs
-
What is Medicxi III?
Medicxi III is a venture capital fund managed by Medicxi.
-
Who manages Medicxi III?
Medicxi III is managed by Medicxi.
-
Where is Medicxi III domiciled?
Medicxi III is domiciled in United Kingdom: Jersey.
-
What is Medicxi III's size?
Medicxi III has a size of $452M.
-
What type of fund is Medicxi III?
The fund type of Medicxi III is Venture.
-
What is the status of Medicxi III?
Medicxi III is closed.
-
What has Medicxi III invested in?
Medicxi III has made numerous investments in companies like Altesa BioSciences, Graegis Pharmaceuticals, and T-Cypher Bio within the Drug Discovery and Drug Delivery industries.
-
What has Medicxi III invested in recently?
Medicxi III's latest investment was on 22-Jun-2023 in Altesa BioSciences, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
